An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalIntervention: Drug: GWP42003-PSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalInterventions: Drug: GWP42003-P; Drug: PlaceboSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalIntervention: Drug: GWP42003-PSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalInterventions: Drug: GWP42003-P; Drug: PlaceboSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalIntervention: Drug: GWP42003-PSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalInterventions: Drug: GWP42003-P; Drug: PlaceboSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalIntervention: Drug: GWP42003-PSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalInterventions: Drug: GWP42003-P; Drug: PlaceboSponsor: GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials